InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
10
T+90 hit rate
100%
T+90 mean return
+62.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by van Houte Hans, Chief Financial Officer. Director active across 1 company, notably Nurix Therapeutics, Inc.. In total, 26 filings have been recorded. Split: 0 buy · 10 sells. Total volume traded: €1.3m. History available since 30 April 2022. The latest transaction was filed on 30 October 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations26 total
2,886 shares0Common StockSEC:0001817217-25-000003
2,886 shares0Common StockSEC:0001817217-25-000003:0
6,198 shares@ US$11.33314.5% of flowCommon StockSEC:0001549595-25-000063:0
2,886 shares0Common StockSEC:0001549595-25-000059:0
5,125 shares@ US$14.39945.1% of flowCommon StockSEC:0001549595-25-000037:0
2,886 shares0Common StockSEC:0001549595-25-000020:0
3,546 shares@ US$24.27625.7% of flowCommon StockSEC:0001549595-24-000153:0
2,886 shares0Common StockSEC:0001549595-24-000148:0
20,000 shares@ US$25.218532.4% of flowCommon StockSEC:0001549595-24-000112:0
3,377 shares@ US$21.42554.8% of flowCommon StockSEC:0001549595-24-000110:0
2,886 shares0Common StockSEC:0001549595-24-000104:0
20,000 shares@ US$20.010826.8% of flowCommon StockSEC:0001549595-24-000088:0
3,499 shares@ US$12.8263.0% of flowCommon StockSEC:0001549595-24-000057:0
2,886 shares0Common StockSEC:0001549595-24-000055:0
6,812 shares@ US$10.01514.5% of flowCommon StockSEC:0001549595-24-000034:0
2,886 shares0Common StockSEC:0001549595-24-000009:0
3,541 shares@ US$10.00312.3% of flowCommon StockSEC:0001549595-23-000066:0
10,906 shares@ US$10.0037.2% of flowCommon StockSEC:0001549595-23-000064:0
2,886 shares0Common StockSEC:0001549595-23-000060:0
2,886 shares0Common StockSEC:0001209191-23-043982:0
2,886 shares0Common StockSEC:0001209191-23-026522:0
2,886 shares0Common StockSEC:0001209191-23-005908:0
2,886 shares0Common StockSEC:0001209191-22-055146:0
2,886 shares0Common StockSEC:0001209191-22-043962:0
68,333 shares@ US$0.840.0030% mcap100.0% of flowCommon StockSEC:0001209191-22-033200:0
25 of 26 declarations
About van Houte Hans
Hans van Houte is the Chief Financial Officer at Nurix Therapeutics, Inc. He is responsible for financial management and strategy for the company. His financial expertise is crucial for supporting Nurix's growth and sustainability.
